Regeneron Pharmaceuticals financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

리제네론 파머슈티컬스NASDAQ:REGN · Nasdaq · Healthcare · sector #17

$742.12+0.46%

2026-10-07 close · prelim

Regeneron Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $14.2B. 2024 operating profit was $3.99B.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy